Its cellular therapy approach uses adult stem cells from fat tissue for all of its research, particularly in creating safe and efficient medications the company can mass-produce to make them affordable on the market. Stem Cell Research Stocks Cellular Biomedicine Group (NASDAQ: CBMG)Īnother champion of regenerative medicine is Cellular Biomedicine Group, with corporate headquarters in Maryland and a research facility in Shanghai, China. Ready to build your portfolio? With you can follow other investors, discover companies that are inline with your beliefs, and invest into stocks and crypto with very little money! What are you waiting for? Check out Public Now! The company’s stem cell research could be a breakthrough in slowing or eliminating these diseases as they are not yet curable.įrom an investor’s standpoint, it could mean massive capital growth in the following years. It is also performing preclinical trials on stem cell drugs against Huntington’s disease (HD), Parkinson’s disease (PD), and autism spectrum disorder.īrainStorm Cell Therapeutics has developed a proprietary cellular technology platform called NurOwn to treat these diseases. The company has medications in the pipeline to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) and progressive multiple sclerosis, which has already been cleared for a phase III clinical trial. Headquartered in New York, BrainStorm Cell Therapeutics looks to combat degenerative diseases using stem cells found in a patient’s bone marrow (autologous harvesting).Īlthough the company doesn’t have stem cell products, many are already in clinical development.
To kickstart your research, take a look at our picks for stem cell stocks to watch out for.īest Stem Cell Stocks BrainStorm Cell Therapeutics (NASDAQ: BCLI) Researchers have also been testing cellular therapies for years as a potential treatment for a broad range of diseases like cancer, diabetes, cardiovascular diseases, and other neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease.Īdditionally, researchers can use stem cells as a safe way to test new drugs before using human patients since they can program the cells to become a specific type of tissue.ĭespite the vast potential of cell therapy, it remains a young technology, and investors who want to bank on it need to know the best publicly listed stem cell stocks.
Stem cells are essentially the body’s base that every other type forms from, so scientists can use them to replace damaged ones. Healthcare researchers are working on regenerative medicine solutions, mainly stem cells. There’s a lot of buzz around stem cells stocks, and for a good reason: stem cell technology is one of the most promising innovations in the medical field.
8.5 How Can I Invest in Stem Cell Technology?